266 related articles for article (PubMed ID: 23110523)
1. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
[TBL] [Abstract][Full Text] [Related]
2. Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells.
Horibata S; Vo TV; Subramanian V; Thompson PR; Coonrod SA
J Vis Exp; 2015 May; (99):e52727. PubMed ID: 26067809
[TBL] [Abstract][Full Text] [Related]
3. PADI2-Mediated Citrullination Promotes Prostate Cancer Progression.
Wang L; Song G; Zhang X; Feng T; Pan J; Chen W; Yang M; Bai X; Pang Y; Yu J; Han J; Han B
Cancer Res; 2017 Nov; 77(21):5755-5768. PubMed ID: 28819028
[TBL] [Abstract][Full Text] [Related]
4. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
5. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
[TBL] [Abstract][Full Text] [Related]
6. Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.
Funayama R; Taniguchi H; Mizuma M; Fujishima F; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Cancer Sci; 2017 Apr; 108(4):713-718. PubMed ID: 28403548
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
8. Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Gao BS; Rong CS; Xu HM; Sun T; Hou J; Xu Y
Pathol Oncol Res; 2020 Apr; 26(2):1279-1285. PubMed ID: 31267364
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.
Cantariño N; Musulén E; Valero V; Peinado MA; Perucho M; Moreno V; Forcales SV; Douet J; Buschbeck M
Mol Cancer Res; 2016 Sep; 14(9):841-8. PubMed ID: 27280713
[TBL] [Abstract][Full Text] [Related]
10. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
Chumanevich AA; Causey CP; Knuckley BA; Jones JE; Poudyal D; Chumanevich AP; Davis T; Matesic LE; Thompson PR; Hofseth LJ
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G929-38. PubMed ID: 21415415
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
Li F; Miao L; Xue T; Qin H; Mondal S; Thompson PR; Coonrod SA; Liu X; Zhang X
J Exp Clin Cancer Res; 2019 Oct; 38(1):414. PubMed ID: 31601253
[TBL] [Abstract][Full Text] [Related]
12. Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells.
Hsu PC; Liao YF; Lin CL; Lin WH; Liu GY; Hung HC
Mol Cells; 2014 May; 37(5):426-34. PubMed ID: 24850148
[TBL] [Abstract][Full Text] [Related]
13. Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
Shekhar MP; Tait L; Pauley RJ; Wu GS; Santner SJ; Nangia-Makker P; Shekhar V; Nassar H; Visscher DW; Heppner GH; Miller FR
Cancer Biol Ther; 2008 Nov; 7(11):1774-82. PubMed ID: 18787417
[TBL] [Abstract][Full Text] [Related]
14. PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling.
Wang H; Xu B; Zhang X; Zheng Y; Zhao Y; Chang X
Cancer Cell Int; 2016; 16():61. PubMed ID: 27478411
[TBL] [Abstract][Full Text] [Related]
15. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
16. PADI2 is significantly associated with rheumatoid arthritis.
Chang X; Xia Y; Pan J; Meng Q; Zhao Y; Yan X
PLoS One; 2013; 8(12):e81259. PubMed ID: 24339914
[TBL] [Abstract][Full Text] [Related]
17. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
Scribner KC; Behbod F; Porter WW
Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
[TBL] [Abstract][Full Text] [Related]
18. The Essential Role of Peptidylarginine Deiminases 2 for Cytokines Secretion, Apoptosis, and Cell Adhesion in Macrophage.
Yu HC; Tung CH; Huang KY; Huang HB; Lu MC
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785008
[TBL] [Abstract][Full Text] [Related]
19. Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.
Guo W; Zheng Y; Xu B; Ma F; Li C; Zhang X; Wang Y; Chang X
Onco Targets Ther; 2017; 10():1475-1485. PubMed ID: 28331341
[TBL] [Abstract][Full Text] [Related]
20. Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.
Witalison EE; Cui X; Causey CP; Thompson PR; Hofseth LJ
Oncotarget; 2015 Nov; 6(34):36053-62. PubMed ID: 26440311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
